<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05530000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P16109</UniProt_ID>
  <Seq_Length>830</Seq_Length>
  <Molecule_Weight>90834</Molecule_Weight>
  <KEGG_ID>hsa:6403</KEGG_ID>
  <Orthology_ID>K06496</Orthology_ID>
  <Function_Summary>Ca(2+)-dependent receptor for myeloid cells that binds to carbohydrates on neutrophils and monocytes. Mediates the interaction of activated endothelial cells or platelets with leukocytes. The ligand recognized is sialyl-Lewis X. Mediates rapid rolling of leukocyte rolling over vascular surfaces during the initial steps in inflammation through interaction with PSGL1.</Function_Summary>
  <Pfam_ID>PF00059:Lectin_C@@PF00084:Sushi</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PADGEM</Alias>
      <Alias>LECAM3</Alias>
      <Alias>GMP-140</Alias>
      <Alias>Platelet activation dependent granule-external membrane protein</Alias>
      <Alias>Leukocyte-endothelial cell adhesion molecule 3</Alias>
      <Alias>Granule membrane protein 140</Alias>
      <Alias>CD62 antigen-like family member P</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.</Detail>
      <Keyword>Glycosphingolipid binding</Keyword>
      <Ontology_ID>GO:0043208</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with lipopolysaccharide.</Detail>
      <Keyword>Lipopolysaccharide binding</Keyword>
      <Ontology_ID>GO:0001530</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with fucose, the pentose 6-deoxygalactose.</Detail>
      <Keyword>Fucose binding</Keyword>
      <Ontology_ID>GO:0042806</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha1-4-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.</Detail>
      <Keyword>Heparin binding</Keyword>
      <Ontology_ID>GO:0008201</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.</Detail>
      <Keyword>Sialic acid binding</Keyword>
      <Ontology_ID>GO:0033691</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.</Detail>
      <Keyword>Oligosaccharide binding</Keyword>
      <Ontology_ID>GO:0070492</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any mono-, di- or trisaccharide carbohydrate.</Detail>
      <Keyword>Sugar binding</Keyword>
      <Ontology_ID>GO:0005529</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>603</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>673</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>365</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>209</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>500</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>661</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>631</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>542</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>385</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>619</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>640</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>756</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.</Detail>
      <Keyword>Defense response to Gram-negative bacterium</Keyword>
      <Ontology_ID>GO:0050829</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.</Detail>
      <Keyword>Positive regulation of platelet activation</Keyword>
      <Ontology_ID>GO:0010572</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.</Detail>
      <Keyword>Response to lipopolysaccharide</Keyword>
      <Ontology_ID>GO:0032496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.</Detail>
      <Keyword>Platelet degranulation</Keyword>
      <Ontology_ID>GO:0002576</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MANCQIAILYQRFQRVVFGISQLLCFSALISELTNQKEVAAWTYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTWTWVGTKKALTNEAENWADNEPNNKRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTASCQDMSCSKQGECLETIGNYTCSCYPGFYGPECEYVRECGELELPQHVLMNCSHPLGNFSFNSQCSFHCTDGYQVNGPSKLECLASGIWTNKPPQCLAAQCPPLKIPERGNMTCLHSAKAFQHQSSCSFSCEEGFALVGPEVVQCTASGVWTAPAPVCKAVQCQHLEAPSEGTMDCVHPLTAFAYGSSCKFECQPGYRVRGLDMLRCIDSGHWSAPLPTCEAISCEPLESPVHGSMDCSPSLRAFQYDTNCSFRCAEGFMLRGADIVRCDNLGQWTAPAPVCQALQCQDLPVPNEARVNCSHPFGAFRYQSVCSFTCNEGLLLVGASVLQCLATGNWNSVPPECQAIPCTPLLSPQNGTMTCVQPLGSSSYKSTCQFICDEGYSLSGPERLDCTRSGRWTDSPPMCEAIKCPELFAPEQGSLDCSDTRGEFNVGSTCHFSCDNGFKLEGPNNVECTTSGRWSATPPTCKGIASLPTPGLQCPALTTPGQGTMYCRHHPGTFGFNTTCYFGCNAGFTLIGDSTLSCRPSGQWTAVTPACRAVKCSELHVNKPIAMNCSNLWGNFSYGSICSFHCLEGQLLNGSAQTACQENGHWSTTVPTCQAGPLTIQEALTYFGGAVASTIGLIMGGTLLALLRKRFRQKDDGKCPLNPHSHLGTYGVFTNAAFDPSP</Protein_Seq>
    <DNA_Seq>GGCAGTGAGACTGTAAGCAGTCTGGGTTGGGCAGAAGGCAGAAAACCAGCAGAGTCACAGAGGAGATGGCCAACTGCCAAATAGCCATCTTGTACCAGAGATTCCAGAGAGTGGTCTTTGGAATTTCCCAACTCCTTTGCTTCAGTGCCCTGATCTCTGAACTAACAAACCAGAAAGAAGTGGCAGCATGGACTTATCATTACAGCACAAAAGCATACTCATGGAATATTTCCCGTAAATACTGCCAGAATCGCTACACAGACTTAGTGGCCATCCAGAATAAAAATGAAATTGATTACCTCAATAAGGTCCTACCCTACTACAGCTCCTACTACTGGATTGGGATCCGAAAGAACAATAAGACATGGACATGGGTGGGAACCAAAAAGGCTCTCACCAACGAGGCTGAGAACTGGGCTGATAATGAACCTAACAACAAAAGGAACAACGAGGACTGCGTGGAGATATACATCAAGAGTCCGTCAGCCCCTGGCAAGTGGAATGATGAGCACTGCTTGAAGAAAAAGCACGCATTGTGTTACACAGCCTCCTGCCAGGACATGTCCTGCAGCAAACAAGGAGAGTGCCTCGAGACCATCGGGAACTACACCTGCTCCTGTTACCCTGGATTCTATGGGCCAGAATGTGAATACGTGAGAGAGTGTGGAGAACTTGAGCTCCCTCAACACGTGCTCATGAACTGCAGCCACCCTCTGGGAAACTTCTCTTTTAACTCGCAGTGCAGCTTCCACTGCACTGACGGGTACCAAGTAAATGGGCCCAGCAAGCTGGAATGCTTGGCTTCTGGAATCTGGACAAATAAGCCTCCACAGTGTTTAGCTGCCCAGTGCCCACCCCTGAAGATTCCTGAACGAGGAAACATGACCTGCCTTCATTCTGCAAAAGCATTCCAGCATCAGTCTAGCTGCAGCTTCAGTTGTGAAGAGGGATTTGCATTAGTTGGACCGGAAGTGGTGCAATGCACAGCCTCGGGGGTATGGACAGCCCCAGCCCCAGTGTGTAAAGCTGTGCAGTGTCAGCACCTGGAAGCCCCCAGTGAAGGAACCATGGACTGTGTTCATCCGCTCACTGCTTTTGCCTATGGCTCCAGCTGTAAATTTGAGTGCCAGCCCGGCTACAGAGTGAGGGGCTTGGACATGCTCCGCTGCATTGACTCTGGACACTGGTCTGCACCCTTGCCAACCTGTGAGGCTATTTCGTGTGAGCCGCTGGAGAGTCCTGTCCACGGAAGCATGGATTGCTCTCCATCCTTGAGAGCGTTTCAGTATGACACCAACTGTAGCTTCCGCTGTGCTGAAGGTTTCATGCTGAGAGGAGCCGATATAGTTCGGTGTGATAACTTGGGACAGTGGACAGCACCAGCCCCAGTCTGTCAAGCTTTGCAGTGCCAGGATCTCCCAGTTCCAAATGAGGCCCGGGTGAACTGCTCCCACCCCTTCGGTGCCTTTAGGTACCAGTCAGTCTGCAGCTTCACCTGCAATGAAGGCTTGCTCCTGGTGGGAGCAAGTGTGCTACAGTGCTTGGCTACTGGAAACTGGAATTCTGTTCCTCCAGAATGCCAAGCCATTCCCTGCACACCTTTGCTAAGCCCTCAGAATGGAACAATGACCTGTGTTCAACCTCTTGGAAGTTCCAGTTATAAATCCACATGTCAATTCATCTGTGACGAGGGATATTCTTTGTCTGGACCAGAAAGATTGGATTGTACTCGATCGGGACGCTGGACAGACTCCCCACCAATGTGTGAAGCCATCAAGTGCCCAGAACTCTTTGCCCCAGAGCAGGGCAGCCTGGATTGTTCTGACACTCGTGGAGAATTCAATGTTGGCTCCACCTGCCATTTCTCTTGTGACAACGGCTTTAAGCTGGAGGGGCCCAATAATGTGGAATGCACAACTTCTGGAAGATGGTCAGCTACTCCACCAACCTGCAAAGGCATAGCATCACTTCCTACTCCAGGGGTGCAATGTCCAGCCCTCACCACTCCTGGGCAGGGAACCATGTACTGTAGGCATCATCCGGGAACCTTTGGTTTTAATACCACTTGTTACTTTGGCTGCAACGCTGGATTCACACTCATAGGAGACAGCACTCTCAGCTGCAGACCTTCAGGACAATGGACAGCAGTAACTCCAGCATGCAGAGCTGTGAAATGCTCAGAACTACATGTTAATAAGCCAATAGCGATGAACTGCTCCAACCTCTGGGGAAACTTCAGTTATGGATCAATCTGCTCTTTCCATTGTCTAGAGGGCCAGTTACTTAATGGCTCTGCACAAACAGCATGCCAAGAGAATGGCCACTGGTCAACTACCGTGCCAACCTGCCAAGCAGGACCATTGACTATCCAGGAAGCCCTGACTTACTTTGGTGGAGCGGTGGCTTCTACGATAGGTCTGATAATGGGTGGGACGCTCCTGGCTTTGCTAAGAAAGCGTTTCAGACAAAAAGATGATGGGAAATGCCCCTTGAATCCTCACAGCCACCTAGGAACATATGGAGTTTTTACAAACGCTGCATTTGACCCGAGTCCTTAAGGTTTCCATAAACACCCATGAATCAAAGACATGGAATTACCTTAGATTAGCTCTGGACCAGCCTGTTGGACCCGCTCTGGACCAACCCTGTTTCCTGAGTTTGGGATTGTGGTACAATCTCAAATTCTCAACCTACCACCCCTTCCTGTCCCACCTCTTCTCTTCCTGTAACACAAGCCACAGAAGCCAGGAGCAAATGTTTCTGCAGTAGTCTCTGTGCTTTGACTCACCTGTTACTTGAAATACCAGTGAACCAAAGAGACTGGAGCATCTGACTCACAAGAAGACCAGACTGTGGAGAAATAAAAATACCTCTTTATTTTTTGATTGAAGGAAGGTTTTCTCCACTTTGTTGGAAAGCAGGTGGCATCTCTAATTGGAAGAAATTCCTGTAGCATCTTCTGGAGTCTCCAGTGGTTGCTGTTGATGAGGCCTCTTGGACCTCTGCTCTGAGGCTTCCAGAGAGTCCTCTGGATGGCACCAGAGGCTGCAGAAGGCCAAGAATCAAGCTAGAAGGCCACATGTCACCGTGGACCTTCCTGCCACCAGTCACTGTCCCTCAAATGACCCAAAGACCAATATTCAAATGCGTAATTAAAAGAATTTTCCCCAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Platelets</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Endothelial cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane fraction</CellLocal>
      <Ontology_ID>GO:0005624</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Platelet alpha granule membrane</CellLocal>
      <Ontology_ID>GO:0031092</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Soluble fraction</CellLocal>
      <Ontology_ID>GO:0005625</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Platelet dense granule membrane</CellLocal>
      <Ontology_ID>GO:0031088</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>External side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0009897</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SELP</Gene_Name>
    <Gene_Alias>GMRP; GRMP</Gene_Alias>
    <Gene_ID>6403</Gene_ID>
    <Genbank_ACCN>NM_003005</Genbank_ACCN>
    <Protein_ACCN>NP_002996</Protein_ACCN>
    <HGNC_ID>10721</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/6403</Gene_URL>
    <EMBL_ID>ENSG00000174175</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Arteriosclerosis</Disease_Name>
      <Disease_Detail>Arteriosclerosis</Disease_Detail>
      <Disease_DB>ART021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriosclerosis?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Vascular Occlusion</Disease_Name>
      <Disease_Detail>Retinal Vascular Occlusion</Disease_Detail>
      <Disease_DB>RTN021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_vascular_occlusion?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Common Cold</Disease_Name>
      <Disease_Detail>Common Cold</Disease_Detail>
      <Disease_DB>CMM005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/common_cold?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type 2b Von Willebrand Disease</Disease_Name>
      <Disease_Detail>Von Willebrand Disease</Disease_Detail>
      <Disease_DB>TYP015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_2b_von_willebrand_disease?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Carotid Stenosis</Disease_Name>
      <Disease_Detail>Carotid Stenosis</Disease_Detail>
      <Disease_DB>CRT013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/carotid_stenosis?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>End Stage Renal Failure</Disease_Name>
      <Disease_Detail>End Stage Renal Failure</Disease_Detail>
      <Disease_DB>END030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/end_stage_renal_failure?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malaria</Disease_Name>
      <Disease_Detail>Malaria</Disease_Detail>
      <Disease_DB>MLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malaria?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vascular Disease</Disease_Name>
      <Disease_Detail>Vascular Disease</Disease_Detail>
      <Disease_DB>VSC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vascular_disease?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gray Platelet Syndrome</Disease_Name>
      <Disease_Detail>Gray Platelet Syndrome</Disease_Detail>
      <Disease_DB>GRY002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gray_platelet_syndrome?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intermittent Claudication</Disease_Name>
      <Disease_Detail>Intermittent Claudication</Disease_Detail>
      <Disease_DB>INT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intermittent_claudication?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mitral Valve Disease</Disease_Name>
      <Disease_Detail>Mitral Valve Disease</Disease_Detail>
      <Disease_DB>MTR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mitral_valve_disease?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Autoimmune Thrombocytopenic Purpura</Disease_Name>
      <Disease_Detail>Autoimmune Thrombocytopenic Purpura</Disease_Detail>
      <Disease_DB>ATM004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/autoimmune_thrombocytopenic_purpura?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type 2 Diabetes Mellitus</Disease_Name>
      <Disease_Detail>Diabetes Mellitus</Disease_Detail>
      <Disease_DB>TYP009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_2_diabetes_mellitus?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arteriosclerosis Obliterans</Disease_Name>
      <Disease_Detail>Arteriosclerosis Obliterans</Disease_Detail>
      <Disease_DB>ART008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriosclerosis_obliterans?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukocyte Adhesion Deficiency</Disease_Name>
      <Disease_Detail>Leukocyte Adhesion Deficiency</Disease_Detail>
      <Disease_DB>LKC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukocyte_adhesion_deficiency?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Quebec Platelet Disorder</Disease_Name>
      <Disease_Detail>Quebec Platelet Disorder</Disease_Detail>
      <Disease_DB>QBC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/quebec_platelet_disorder?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Purpura</Disease_Name>
      <Disease_Detail>Purpura</Disease_Detail>
      <Disease_DB>PRP030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/purpura?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Von Willebrand's Disease</Disease_Name>
      <Disease_Detail>Von Willebrand's Disease</Disease_Detail>
      <Disease_DB>VNW001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/von_willebrands_disease?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pre-Eclampsia</Disease_Name>
      <Disease_Detail>Pre-Eclampsia</Disease_Detail>
      <Disease_DB>PRC016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pre_eclampsia?search=SELP#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atopy</Disease_Name>
      <Disease_Detail>Atopy</Disease_Detail>
      <Disease_DB>ATP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atopy?search=SELP#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of P-selectin lectin/EGF domains complexed with SLeX</PDB_Title>
      <PDB_ID>1G1R</PDB_ID>
      <Resolution>3.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1G1R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.</PubMed_Title>
      <Author>Somers, W.S., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2000)103:467-479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11081633?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of P-selectin lectin/EGF domains</PDB_Title>
      <PDB_ID>1G1Q</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1G1Q</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.</PubMed_Title>
      <Author>Somers, W.S., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2000)103:467-479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11081633?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE</PDB_Title>
      <PDB_ID>1G1S</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1G1S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.</PubMed_Title>
      <Author>Somers, W.S., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2000)103:467-479</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11081633?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE EGF DOMAIN OF P-SELECTIN, NMR, 19 STRUCTURES</PDB_Title>
      <PDB_ID>1FSB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FSB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and function of the epidermal growth factor domain of P-selectin.</PubMed_Title>
      <Author>Freedman, S.J., et al.</Author>
      <Journal>Biochemistry(1996)35:13733-13744</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8901515?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH P-SELECTIN INTERNALIZATION PEPTIDE SHLGTYGVFTNAA</PDB_Title>
      <PDB_ID>1HES</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HES</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Third Specificity-Determining Site in Mu 2 Adaptin for Sequences Upstream of Yxx Phi Sorting Motifs</PubMed_Title>
      <Author>Owen, D.J., et al.</Author>
      <Journal>Traffic(2001)2:105</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11247301?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05150</Pathway_ID>
      <Pathway_Title>Staphylococcus aureus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05144</Pathway_ID>
      <Pathway_Title>Malaria</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04514</Pathway_ID>
      <Pathway_Title>Cell adhesion molecules (CAMs)</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04514</Pathway_ID>
      <Pathway_Title>Cell adhesion molecules (CAMs)</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ddh.b.b.ea.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1g1q</CATH_URL>
  </Fold>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>